Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
13.35
-0.06 (-0.45%)
At close: Jun 18, 2025, 4:00 PM
13.35
0.00 (0.00%)
After-hours: Jun 18, 2025, 4:10 PM EDT
Pediatrix Medical Group Stock Forecast
Stock Price Forecast
The 6 analysts that cover Pediatrix Medical Group stock have a consensus rating of "Buy" and an average price target of $16.67, which forecasts a 24.87% increase in the stock price over the next year. The lowest target is $15 and the highest is $20.
Price Target: $16.67 (+24.87%)
Analyst Consensus: Buy
* Price targets were last updated on May 12, 2025.
Analyst Ratings
The average analyst rating for Pediatrix Medical Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 5 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $19 → $16 | Hold | Maintains | $19 → $16 | +19.85% | May 12, 2025 |
| Macquarie | Macquarie | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | +49.81% | May 8, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $18 → $16 | Hold | Maintains | $18 → $16 | +19.85% | Apr 11, 2025 |
| UBS | UBS | Hold Maintains $17 → $19 | Hold | Maintains | $17 → $19 | +38.58% | Feb 21, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $15 → $18 | Hold | Maintains | $15 → $18 | +34.83% | Feb 21, 2025 |
Financial Forecast
Revenue This Year
1.93B
from 2.01B
Decreased by -4.12%
Revenue Next Year
1.99B
from 1.93B
Increased by 3.26%
EPS This Year
1.68
from -1.19
EPS Next Year
1.75
from 1.68
Increased by 4.39%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.1B | 2.1B | 2.2B | ||
| Avg | 1.9B | 2.0B | 2.1B | ||
| Low | 1.8B | 1.8B | 1.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.0% | 10.2% | 12.6% | ||
| Avg | -4.1% | 3.3% | 4.9% | ||
| Low | -9.9% | -5.9% | -3.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.82 | 1.93 | 2.18 | ||
| Avg | 1.68 | 1.75 | 1.81 | ||
| Low | 1.38 | 1.57 | 1.60 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 15.2% | 24.5% | ||
| Avg | - | 4.4% | 3.6% | ||
| Low | - | -6.5% | -8.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.